ClinicalTrialsFinder
RecruitingNot ApplicableNCT07195708

Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')

Clinical Study to Evaluate the Safety and Efficacy of the Orbera365 Intragastric Balloon System in Obese Patients

Sponsor

Boston Scientific Corporation

Enrollment

144 participants

Start Date

Jun 3, 2026

Study Type

INTERVENTIONAL

Conditions

Weight Loss

Summary

To demonstrate the safety and efficacy of Orbera365 in obese populations to support the registration of Orbera365.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Treatment group for people with weight loss. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETreatment group

The treatment group was the group with the placement of Orbera 365 plus lifestyle management

Locations(1)

Shanghai Changhai Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07195708

Related Trials

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

NCT007393621 location

Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass

NCT070154249 locations

Exercise Effects on Adipose Tissue Structure and Function

NCT048123141 location

A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function

NCT075407541 location

Metabolic Health, Bones and Nuts During Weight Loss in Adults

NCT069492801 location